PCSK9-targeted Therapy Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194402 | Category: Service & Software | Pages: 67 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

This report aims to provide a comprehensive presentation of the global market for PCSK9-targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PCSK9-targeted Therapy. This report contains market size and forecasts of PCSK9-targeted Therapy in global, including the following market information:
Global PCSK9-targeted Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global PCSK9-targeted Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Subcutaneous Injection Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of PCSK9-targeted Therapy include Novo Nordisk, Sanofi, Regeneron, Amgen, Novartis, Hengrui Pharma, TopAlliance Biosciences, Innovent Biologics, Inc. and Akeso, Inc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PCSK9-targeted Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PCSK9-targeted Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global PCSK9-targeted Therapy Market Segment Percentages, by Type, 2022 (%)
    Subcutaneous Injection
    Oral
Global PCSK9-targeted Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global PCSK9-targeted Therapy Market Segment Percentages, by Application, 2022 (%)
    CVD
    Tumor
    Acne
    Others
Global PCSK9-targeted Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global PCSK9-targeted Therapy Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PCSK9-targeted Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies PCSK9-targeted Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Novo Nordisk
    Sanofi
    Regeneron
    Amgen
    Novartis
    Hengrui Pharma
    TopAlliance Biosciences
    Innovent Biologics, Inc.
    Akeso, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of PCSK9-targeted Therapy, market overview.
Chapter 2: Global PCSK9-targeted Therapy market size in revenue.
Chapter 3: Detailed analysis of PCSK9-targeted Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of PCSK9-targeted Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 PCSK9-targeted Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global PCSK9-targeted Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global PCSK9-targeted Therapy Overall Market Size
    2.1 Global PCSK9-targeted Therapy Market Size: 2022 VS 2029
    2.2 Global PCSK9-targeted Therapy Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top PCSK9-targeted Therapy Players in Global Market
    3.2 Top Global PCSK9-targeted Therapy Companies Ranked by Revenue
    3.3 Global PCSK9-targeted Therapy Revenue by Companies
    3.4 Top 3 and Top 5 PCSK9-targeted Therapy Companies in Global Market, by Revenue in 2022
    3.5 Global Companies PCSK9-targeted Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 PCSK9-targeted Therapy Players in Global Market
        3.6.1 List of Global Tier 1 PCSK9-targeted Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 PCSK9-targeted Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global PCSK9-targeted Therapy Market Size Markets, 2022 & 2029
        4.1.2 Subcutaneous Injection
        4.1.3 Oral
    4.2 By Type - Global PCSK9-targeted Therapy Revenue & Forecasts
        4.2.1 By Type - Global PCSK9-targeted Therapy Revenue, 2018-2023
        4.2.2 By Type - Global PCSK9-targeted Therapy Revenue, 2024-2029
        4.2.3 By Type - Global PCSK9-targeted Therapy Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global PCSK9-targeted Therapy Market Size, 2022 & 2029
        5.1.2 CVD
        5.1.3 Tumor
        5.1.4 Acne
        5.1.5 Others
    5.2 By Application - Global PCSK9-targeted Therapy Revenue & Forecasts
        5.2.1 By Application - Global PCSK9-targeted Therapy Revenue, 2018-2023
        5.2.2 By Application - Global PCSK9-targeted Therapy Revenue, 2024-2029
        5.2.3 By Application - Global PCSK9-targeted Therapy Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global PCSK9-targeted Therapy Market Size, 2022 & 2029
    6.2 By Region - Global PCSK9-targeted Therapy Revenue & Forecasts
        6.2.1 By Region - Global PCSK9-targeted Therapy Revenue, 2018-2023
        6.2.2 By Region - Global PCSK9-targeted Therapy Revenue, 2024-2029
        6.2.3 By Region - Global PCSK9-targeted Therapy Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America PCSK9-targeted Therapy Revenue, 2018-2029
        6.3.2 US PCSK9-targeted Therapy Market Size, 2018-2029
        6.3.3 Canada PCSK9-targeted Therapy Market Size, 2018-2029
        6.3.4 Mexico PCSK9-targeted Therapy Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe PCSK9-targeted Therapy Revenue, 2018-2029
        6.4.2 Germany PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.3 France PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.4 U.K. PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.5 Italy PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.6 Russia PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.7 Nordic Countries PCSK9-targeted Therapy Market Size, 2018-2029
        6.4.8 Benelux PCSK9-targeted Therapy Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia PCSK9-targeted Therapy Revenue, 2018-2029
        6.5.2 China PCSK9-targeted Therapy Market Size, 2018-2029
        6.5.3 Japan PCSK9-targeted Therapy Market Size, 2018-2029
        6.5.4 South Korea PCSK9-targeted Therapy Market Size, 2018-2029
        6.5.5 Southeast Asia PCSK9-targeted Therapy Market Size, 2018-2029
        6.5.6 India PCSK9-targeted Therapy Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America PCSK9-targeted Therapy Revenue, 2018-2029
        6.6.2 Brazil PCSK9-targeted Therapy Market Size, 2018-2029
        6.6.3 Argentina PCSK9-targeted Therapy Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa PCSK9-targeted Therapy Revenue, 2018-2029
        6.7.2 Turkey PCSK9-targeted Therapy Market Size, 2018-2029
        6.7.3 Israel PCSK9-targeted Therapy Market Size, 2018-2029
        6.7.4 Saudi Arabia PCSK9-targeted Therapy Market Size, 2018-2029
        6.7.5 UAE PCSK9-targeted Therapy Market Size, 2018-2029
7 PCSK9-targeted Therapy Companies Profiles
    7.1 Novo Nordisk
        7.1.1 Novo Nordisk Company Summary
        7.1.2 Novo Nordisk Business Overview
        7.1.3 Novo Nordisk PCSK9-targeted Therapy Major Product Offerings
        7.1.4 Novo Nordisk PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.1.5 Novo Nordisk Key News & Latest Developments
    7.2 Sanofi
        7.2.1 Sanofi Company Summary
        7.2.2 Sanofi Business Overview
        7.2.3 Sanofi PCSK9-targeted Therapy Major Product Offerings
        7.2.4 Sanofi PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.2.5 Sanofi Key News & Latest Developments
    7.3 Regeneron
        7.3.1 Regeneron Company Summary
        7.3.2 Regeneron Business Overview
        7.3.3 Regeneron PCSK9-targeted Therapy Major Product Offerings
        7.3.4 Regeneron PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.3.5 Regeneron Key News & Latest Developments
    7.4 Amgen
        7.4.1 Amgen Company Summary
        7.4.2 Amgen Business Overview
        7.4.3 Amgen PCSK9-targeted Therapy Major Product Offerings
        7.4.4 Amgen PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.4.5 Amgen Key News & Latest Developments
    7.5 Novartis
        7.5.1 Novartis Company Summary
        7.5.2 Novartis Business Overview
        7.5.3 Novartis PCSK9-targeted Therapy Major Product Offerings
        7.5.4 Novartis PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.5.5 Novartis Key News & Latest Developments
    7.6 Hengrui Pharma
        7.6.1 Hengrui Pharma Company Summary
        7.6.2 Hengrui Pharma Business Overview
        7.6.3 Hengrui Pharma PCSK9-targeted Therapy Major Product Offerings
        7.6.4 Hengrui Pharma PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.6.5 Hengrui Pharma Key News & Latest Developments
    7.7 TopAlliance Biosciences
        7.7.1 TopAlliance Biosciences Company Summary
        7.7.2 TopAlliance Biosciences Business Overview
        7.7.3 TopAlliance Biosciences PCSK9-targeted Therapy Major Product Offerings
        7.7.4 TopAlliance Biosciences PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.7.5 TopAlliance Biosciences Key News & Latest Developments
    7.8 Innovent Biologics, Inc.
        7.8.1 Innovent Biologics, Inc. Company Summary
        7.8.2 Innovent Biologics, Inc. Business Overview
        7.8.3 Innovent Biologics, Inc. PCSK9-targeted Therapy Major Product Offerings
        7.8.4 Innovent Biologics, Inc. PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.8.5 Innovent Biologics, Inc. Key News & Latest Developments
    7.9 Akeso, Inc
        7.9.1 Akeso, Inc Company Summary
        7.9.2 Akeso, Inc Business Overview
        7.9.3 Akeso, Inc PCSK9-targeted Therapy Major Product Offerings
        7.9.4 Akeso, Inc PCSK9-targeted Therapy Revenue in Global Market (2018-2023)
        7.9.5 Akeso, Inc Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

PCSK9-targeted Therapy Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?